Mitochondria play a critical role in energy homeostasis as the primary site of adenosine triphosphate production. Energy regulation is also dependent on proteins translated from genes encoded in mitochondrial DNA (mtDNA), a 16.7-kb circular DNA molecule. Mitochondrial dysfunction, a hallmark of the aging process, disrupts energy homeostasis and is believed to be a core component of several chronic conditions including cardiovascular disease (CVD).
1 Mitochondrial dysfunction may also play a critical role in the initiation and progression of atherosclerosis, the primary pathological lesion underlying CVD. Evidence for this hypothesis is derived from both model organisms and human studies. First, in
ApoE knockout mouse models of hyperlipidemia, mtDNA damage occurs prior to plaque formation, and there is significant correlation between mtDNA damage and extent of atherosclerosis in
ApoE and human aorta specimens.
2 Second, a study using
polG knockout mice (which results in elevated rates of mtDNA mutations) and bone marrow transplants into
ApoE knockout mice demonstrated that circulating cells increased the necrotic core and decreased the fibrous cap, which are key features of plaque instability.
3 Finally, in humans, white blood cell (WBC) mtDNA damage has been associated with high-risk atherosclerotic plaques.
3